EUCTR2005-001721-29-IT进行中（未招募）不适用
An Open-Label, Single-Arm, Multi-Center, Phase 2 Study of Troxatyl troxacitabine Administered by Continuous Infusion in Patients with Acute Myeloid Leukemia AML in Second Salvage
STRUCTURAL GENOMIX0 个研究点目标入组 211 人开始时间: 2007年1月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 211
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
招募中
不适用
A Phase 2 study of Pemetrexed/Cisplatin Chemotherapy for Patients With Metastatic/Recurrent Soft Tissue SarcomaNeoplasmsKCT0005369Yonsei University Health System, Severance Hospital164
进行中（未招募）
1 期
A study of investigational medicinal product AL101 in adults who have adenoid cystic carcinoma, and a specific genetic alteration in a gene called Notch, that has come back or did not get better with a previous therapyMedDRA version: 20.0Level: PTClassification code 10053231Term: Adenoid cystic carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Adenoid cystic carcinomaEUCTR2019-000309-64-FRAyala Pharmaceuticals, Inc.36
进行中（未招募）
1 期
A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Participants with Advanced Prostate CancerAdvanced prostate cancerMedDRA version: 20.0Level: PTClassification code: 10060862Term: Prostate cancer Class: 100000004864CTIS2023-509255-14-01Antev Limited44
进行中（未招募）
1 期
A Multinational Study to Evaluate the Safety and Activity of Enzalutamide in Women Whose Breast Cancer Expresses the Androgen Receptor but Does Not Express Estrogen or Progesterone Receptors, and is Not Amplified for the Epidermal Growth Factor Receptor, HER2MedDRA version: 14.1Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast CancerEUCTR2013-000698-57-ITMedivation, Inc.80
进行中（未招募）
不适用
A Multinational Study to Evaluate the Safety and Activity of Enzalutamide in Women Whose Breast Cancer Expresses the Androgen Receptor but Does Not Express Estrogen or Progesterone Receptors, and is Not Amplified for the Epidermal Growth Factor Receptor, HER2MedDRA version: 16.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast CancerEUCTR2013-000698-57-ESMedivation, Inc.80